225 related articles for article (PubMed ID: 7756653)
21. Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
Nakazawa N; Nishida K; Tamura A; Kobayashi M; Iwai T; Horiike S; Nishigaki H; Otsuki T; Tomiyama Y; Fujii H; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 2000 Mar; 117(2):89-96. PubMed ID: 10704676
[TBL] [Abstract][Full Text] [Related]
22. Delineation of the breakpoint at 18q21.1 in a cell line (Karpas1106) derived from mediastinal B-cell lymphoma by fluorescence in situ hybridization with multiple YAC clones.
Tamura A; Akagi T; Nakazawa N; Kashima K; Nakamura S; Karpas A; Silverman GA; Morishima Y; Taniwaki M; Seto M
Int J Cancer; 1998 Sep; 78(1):100-5. PubMed ID: 9724100
[TBL] [Abstract][Full Text] [Related]
23. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
24. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
25. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization.
Vaandrager JW; Schuuring E; Zwikstra E; de Boer CJ; Kleiverda KK; van Krieken JH; Kluin-Nelemans HC; van Ommen GJ; Raap AK; Kluin PM
Blood; 1996 Aug; 88(4):1177-82. PubMed ID: 8695834
[TBL] [Abstract][Full Text] [Related]
26. Characterization of chromosome 8 abnormalities by fluorescence in situ hybridization in childhood B-acute lymphoblastic leukemia/non-Hodgkin lymphoma.
Nishida K; Ritterbach J; Repp R; Harbott J; Lampert F
Cancer Genet Cytogenet; 1995 Jan; 79(1):8-14. PubMed ID: 7850758
[TBL] [Abstract][Full Text] [Related]
27. Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization.
Sanchez-Izquierdo D; Siebert R; Harder L; Marugan I; Gozzetti A; Price HP; Gesk S; Hernandez-Rivas JM; Benet I; Solé F; Sonoki T; Le Beau MM; Schlegelberger B; Dyer MJ; Garcia-Conde J; Martinez-Climent JA
Leukemia; 2001 Sep; 15(9):1475-84. PubMed ID: 11516111
[TBL] [Abstract][Full Text] [Related]
28. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
Avet-Loiseau H; Brigaudeau C; Morineau N; Talmant P; Laï JL; Daviet A; Li JY; Praloran V; Rapp MJ; Harousseau JL; Facon T; Bataille R
Genes Chromosomes Cancer; 1999 Jan; 24(1):9-15. PubMed ID: 9892103
[TBL] [Abstract][Full Text] [Related]
29. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
Haluska FG; Tsujimoto Y; Croce CM
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
[TBL] [Abstract][Full Text] [Related]
30. Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization.
Mathew P; Sanger WG; Weisenburger DD; Valentine M; Valentine V; Pickering D; Higgins C; Hess M; Cui X; Srivastava DK; Morris SW
Blood; 1997 Mar; 89(5):1678-85. PubMed ID: 9057650
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.
Kuipers J; Vaandrager JW; Weghuis DO; Pearson PL; Scheres J; Lokhorst HM; Clevers H; Bast BJ
Cancer Genet Cytogenet; 1999 Mar; 109(2):99-107. PubMed ID: 10087940
[TBL] [Abstract][Full Text] [Related]
32. Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization.
Coignet LJ; Schuuring E; Kibbelaar RE; Raap TK; Kleiverda KK; Bertheas MF; Wiegant J; Beverstock G; Kluin PM
Blood; 1996 Feb; 87(4):1512-9. PubMed ID: 8608242
[TBL] [Abstract][Full Text] [Related]
33. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract][Full Text] [Related]
34. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas.
Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Plendl H; Metzke S; Joos S; Zucca E; Weber-Matthiesen K; Roggero E; Grote W; Schlegelberger B
Ann Oncol; 1998 May; 9(5):519-26. PubMed ID: 9653493
[TBL] [Abstract][Full Text] [Related]
35. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.
Baron BW; Nucifora G; McCabe N; Espinosa R; Le Beau MM; McKeithan TW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5262-6. PubMed ID: 8506375
[TBL] [Abstract][Full Text] [Related]
36. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes.
Dierlamm J; Baens M; Stefanova-Ouzounova M; Hinz K; Wlodarska I; Maes B; Steyls A; Driessen A; Verhoef G; Gaulard P; Hagemeijer A; Hossfeld DK; De Wolf-Peeters C; Marynen P
Blood; 2000 Sep; 96(6):2215-8. PubMed ID: 10979968
[TBL] [Abstract][Full Text] [Related]
37. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
38. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
[TBL] [Abstract][Full Text] [Related]
39. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
40. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
